are induced in patients suffering from early-stage septic shock and distinguish them from noninfectious patients with systemic inflammatory response. Methods: The study included 37 patients with early-stage septic shock, 15 patients with noninfectious systemic inflammatory response syndrome (SIRS), and 24 heath controls. We prospectively assayed the fraction of Tregs expressing high levels of CD25 and forkhead box P3 (Foxp3) as well as the plasma levels of interferon-g (IFN-g), interleukin-4 (IL-4), and soluble CD25 in all the subjects studied. (56.45 AE 10.68%), p Z 0.003] in comparison with the SIRS and control groups, which could be differentiated from the patients with SIRS. The plasma levels of soluble CD25 were also increased, and positively correlated with the proportion of Tregs in patients with earlystage septic shock (Spearman correlation coefficient Z 0.390, p Z 0.003).
Introduction
Sepsis is a major cause of death in intensive care units (ICUs), and the hospitalization and mortality rates for severe sepsis are increasing rapidly. 1 It is well known that sepsis undermines immune homeostasis by inducing an initial intense systemic inflammatory response that is rapidly followed by a negative feedback of antiinflammatory processes. 2, 3 The persistence of a marked compensatory anti-inflammatory response following sepsis is termed immunoparalysis. Several studies have reported that this inhibitory response may decrease the resistance of the host against secondary nosocomial infections, which negatively affects the patient's outcome. 4 A recent study showed that patients with severe sepsis suffer from immunosuppression toward the later stages of the disease. 5 However, data from the early stage of the disease remain unclear.
As In this study, we assayed the proportion of CD4 þ CD25 þ Foxp3 þ Tregs and the plasma levels of IFN-g, IL-4, and soluble CD25 in patients with early-stage septic shock. We attempted to find new targets to diagnose sepsis at an early stage and simultaneously evaluate the immune status of these patients. 
Materials and methods

Study population
SIRS group
The patients undergoing elective operations within 24 hours and meeting the diagnostic criteria for SIRS without signs of infection were included. At least two of the following criteria must be present to diagnose SIRS: T > 38 C or < 36 C; heart rate > 90 beats/minute; respiratory rate > 20 breaths/ minute or PaCO 2 < 32 mmHg; white blood cells > 12 or < 4 Â 10 9 /L. 9 
Sepsis group
The patients in ICU are diagnosed with sepsis if they meet the SIRS diagnostic criteria and had evidence of infection, such as positive findings in bacterial cultures of blood or other body fluids. The patients in early-stage septic shock are those who were diagnosed with sepsis within 24 hours. Such patients were also included in this study.
Control group
The control group included age-matched healthy individuals from the Medical Center of Ruijin Hospital.
Study protocol and methods
Peripheral arterial blood from patients with SIRS was collected between 7:00 and 8:00 AM within 24 hours after their operation. Blood was collected from patients with septic shock within 24 hours after the diagnosis. All the samples were anticoagulated with ethylenediaminetetraacetic acid.
Flow cytometry
Lymphocytes were separated from 2.5 mL of peripheral arterial blood by gradient centrifugation in a lymphocyte separation medium within 2 hours after the samples were harvested. The lymphocytes were counted and the cell concentration was diluted to 1 Â 10 6 /mL. A human regulatory T-cell staining kit (Human Regulatory T cell Staining Kit, eBioscience, San Diego, CA, USA) was used, and fluorescein isothiocyanateeconjugated CD4 antibody, APC-CD25 antibody, and PE-Foxp3 antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) were separately added to the diluted lymphocytes. The fluorescence intensity of the cell-surface antibodies was measured by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA, USA), while blank controls and isotype controls were used to eliminate autofluorescence and nonspecific fluorescence. The fluorescence intensity was portrayed as a scattered two-dimensional dot plot, which was 
Results
General information
The age factor was not significantly different among patients in the sepsis group (61.67 AE 11.87) years, the SIRS between the SIRS group and the control group were noted. However, there was no significant difference between the sepsis group and the SIRS group. All statistical data are shown in Table 2 .
The fraction of CD4
D CD25 D Foxp3 D T
cells was significantly elevated at an early stage in patients with septic shock
We assessed the expression of CD4 and CD25, which are the characteristic surface markers of Tregs, and found it to be 1.75% (0.59e2.24%) in the sepsis group, 1.08% (0.63e1.90%) in the SIRS group, and 1.07% (0.80e1.43%) in the control group (Fig. 1) . Although the proportion of CD4 and CD25 was higher in the sepsis group than in the control and SIRS groups, the difference was not statistical significant. However, after the proportion of CD4 The plasma levels of soluble CD25 were significantly increased in patients with early-stage septic shocks
The plasma levels of soluble CD25 (IL-2sRa) were determined to investigate whether the increase in IL-2sRa in the plasma of the sepsis group was accompanied by an increase of CD4 þ CD25 þ Foxp3 þ Tregs. The plasma level of CD25 in the sepsis group was significantly higher than that in the SIRS group and the control group [408.76 (259.85e548.00) pg/mLvs. 345.94 (243.09e520.77) pg/mLvs. 140.33 (110.56e176.12) pg/mL, p < 0.001]. There was also a significant difference between the SIRS group and the control group (Fig. 3A) .
Positive correlation between soluble CD25 and Tregs
We also found that the levels of CD25 cells in the plasma and the proportion of CD4
þ T cells were significantly and positively correlated ( Fig.  3B ; Spearman correlation coefficient Z 0.390, p Z 0.003).
Discussion
Our study showed that IFN-g and IL-4 levels were highly increased in patients with early-stage septic shock when compared with the control, which suggests that the activity of Th1 and Th2 cells has increased. Although IL-4 was higher, IFN-g/IL-4 ratio was still elevated. Therefore, patients who are at the early stage of the sepsis have increased levels of protective Th1 immunity, which was similar to the result of a study involving mice with earlystage septic shock. 10 A previous study showed that Tregs mediated the Th2 predominance in the later stage of the sepsis. 11 Our results suggested IL-4 levels were increased not only in the later stage of the sepsis but also in the early stage. So both pro-and anti-inflammatory responses were activated in patients with early-stage septic shock. The increased IFN-g/IL-4 ratio suggests that the Th1 and Th2 immune responses are imbalanced. However, in early stages, the change in the inflammatory cytokines cannot differentiate sepsis from SIRS.
The principal finding of our study is that that the patients in early sepsis have a significant increase in the proportion of Tregs in their peripheral blood, as previously demonstrated in severe intra-abdominal infections. 10 Although Tregs comprise only a small fraction of the Tlymphocyte population in the immune system, they appear to potently regulate the activation of other cells in the immune system, making them an important participant in the inhibition of the immune response during sepsis. The patients with septic shock may be benefitted from the limitation of exacerbated infection-induced pathology, yet it increases the risk of secondary infection.
We found that the proportion of Tregs in early sepsis is much higher than that in control and SIRS groups, whereas no significant difference was found between the SIRS and control groups. Previous studies also found the same results, but the correlation between the proportion of Tregs and the severity of sepsis in patients remains unclear. 8, 12 It is suggested that the proportion of Tregs may distinguish early-stage sepsis from SIRS. Thus, it may be possible for patients with septic shock to receive more suitable immune regulation treatment at an earlier time, and the manipulation of Treg cells may offer an innovative therapy for patients with septic shock. However, further study is required to understand the conditions under which such a therapy may be effective. Increased proportion of CD4
In our experiment, 80% of the bacteria collected were Gram negative. It is unknown whether the type of bacteria plays a role in the regulation of Tregs in patients with septic shock. Cook et al found that various Toll-like receptors are expressed on the surface of Tregs, including lipopolysaccharide (LPS) receptors such as TLR4. 13 It was previously shown in vivo and in vitro that stimulation with LPS increased the surface markers for Tregs, which indicates the proliferation and inhibition of apoptosis of these cells. 14 CD25 could be produced by activated Tregs, 15 and CD4 þ CD25 þ T cells can express CD25 using certain enzymes (e.g., bromelain). 16 We found that the CD25 levels in plasma were increased, as described in a previous study. 17 We also found that the plasma levels of CD25 were significantly and positively correlated with the proportion of Tregs. Thus, the plasma level of CD25 may reflect the presence of Tregs, suggesting that CD25 may be a convenient marker for the diagnosis of septic shock in patients.
In conclusion, the results of our study indicate that the proportion of CD4
þ T cells can be helpful in the early diagnosis of sepsis. The presence of Tregs reflects the status of immune-suppression in patients with septic shock. Therefore, determining the proportion of CD4 þ CD25 þ Foxp3 þ T cells may allow patients to receive suitable immune-regulation treatment at an early stage. Tregs may also offer an innovative therapy for septic patients in the future.
Limitations
First, the number of the subjects enrolled in this study is not adequate, especially the patients with SIRS, which may bias the analysis. Second, the cause of septic shock in our patients is only due to bacterial infection and thus other infections such as fungi-or virus-induced sepsis were not explored. Third, although we tried to find out whether the sepsis occurred within 24 hours, we could not ensure that all the patients were really in this stage of the disease. Finally, the lack of function assay was another limitation of this study. 
